Yufeng Cheng

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Endoplasmic Reticulum Stress

Cell Cycle Arrest

Locally Advanced

Top Venues

Medical oncology (Northwood, London, England)

Cancer medicine

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Qian Li, Qingxu Song, Zhipeng Zhao, Yang Lin, Yufeng Cheng, Nathan Karin, Yuxia Luan
Genetically Engineered Artificial Exosome-Constructed Hydrogel for Ovarian Cancer Therapy. ACS nano (2023)
Fengyun Wang, Ming Luo, Yufeng Cheng
KLF5 promotes esophageal squamous cell cancer through the transcriptional activation of FGFBP1. Medical oncology (Northwood, London, England) 41 (1) (2023)
Meijie Wang, Xiaozheng Sun, Huixian Xin, Zhihua Wen, Yufeng Cheng
SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma. Cancer medicine (2022)
Wenjing Yang, Bo Cheng, Pengxiang Chen, Xiaozheng Sun, Zhihua Wen, Yufeng Cheng
BTN3A1 promotes tumor progression and radiation resistance in esophageal squamous cell carcinoma by regulating ULK1-mediated autophagy. Cell death & disease 13 (11) (2022)
Wei Zhou, Zhulong Liu, Nana Wang, Xue Chen, Xiaozheng Sun, Yufeng Cheng
Hafnium-Based Metal-Organic Framework Nanoparticles as a Radiosensitizer to Improve Radiotherapy Efficacy in Esophageal Cancer. ACS omega 7 (14) (2022)
Qingxu Song, Pengxiang Chen, Xin Chen, Cong Sun, Jianbo Wang, Bingxu Tan, Hong Liu, Yufeng Cheng
Dynamic Change of Amide Proton Transfer Imaging in Irradiated Nasopharyngeal Carcinoma and Related Histopathological Mechanism. Molecular imaging and biology 23 (6) (2021)
Fengyun Wang, Ming Luo, Honglan Qu, Yufeng Cheng
BAP1 promotes viability and migration of ECA109 cells through KLF5/CyclinD1/FGF-BP1. FEBS open bio 11 (5) (2021)